Chemoinformaics analysis of [(E)-HEX-2-ENYL] HEXANOATE
Molecular Weight | 198.306 | nRot | 8 |
Heavy Atom Molecular Weight | 176.13 | nRig | 2 |
Exact Molecular Weight | 198.162 | nRing | 0 |
Solubility: LogS | -1.378 | nHRing | 0 |
Solubility: LogP | 1.677 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 36 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 14 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 12 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
nHA | 2 | APOL | 36.3134 |
nHD | 0 | BPOL | 24.6746 |
QED | 0.416 |
Synth | 2.281 |
Natural Product Likeliness | 1.575 |
NR-PPAR-gamma | 0.002 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0.003 |
Pgp-sub | 0.001 |
HIA | 0.002 |
CACO-2 | -4.176 |
MDCK | 0.0000283 |
BBB | 0.731 |
PPB | 0.648257 |
VDSS | 1.22 |
FU | 0.47226 |
CYP1A2-inh | 0.959 |
CYP1A2-sub | 0.931 |
CYP2c19-inh | 0.773 |
CYP2c19-sub | 0.809 |
CYP2c9-inh | 0.236 |
CYP2c9-sub | 0.262 |
CYP2d6-inh | 0.18 |
CYP2d6-sub | 0.234 |
CYP3a4-inh | 0.058 |
CYP3a4-sub | 0.315 |
CL | 9.48 |
T12 | 0.794 |
hERG | 0.021 |
Ames | 0.015 |
ROA | 0.02 |
SkinSen | 0.722 |
Carcinogencity | 0.134 |
EI | 0.992 |
Respiratory | 0.26 |
NR-Aromatase | 0.01 |
Antiviral | Yes |
Prediction | 0.594668 |